Altimmune

Altimmune

Late clinical-stage biotech working to improve the lives of those living with serious liver diseases

Location
—
Roles tracked
0
In pipeline
0
Tracking since
—

At a glance

You're tracking 0 roles at Altimmune. Track a role to start building momentum here.

Company intel

From the job board · LinkedIn data via posting sync
Industry
Biotechnology Research
Company size
89 people
Headquarters
Gaithersburg, Maryland
Founded
1997
Type
Public Company
Total funding
$366.4M

Altimmune is a late clinical-stage biopharmaceutical company developing therapies to improve the lives of people living with serious liver diseases. Our lead program is a differentiated dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio, currently in development for metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD) and alcohol-associated liver disease (ALD). #ClinicalResearch #LiverCare #BioResearch

Biotechnology Clinical Trials Health Care Test and Measurement

Open roles at Altimmune